UnknownPhase 2NCT01391481

Perfluorocarbon (PFC) Inhalation Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chinese PLA General Hospital
Principal Investigator
Liangan Chen, M.D. PHD.
Chinese PLA General Hospital
Intervention
Perfluorocarbon(drug)
Enrollment
200 enrolled
Eligibility
18-75 years · All sexes
Timeline
20112015

Study locations (2)

Collaborators

The Second Artillery General Hospital · The 306 Hospital of People's Liberation Army · First Hospitals affiliated to the China PLA General Hospital · General Hospital of Chinese Armed Police Forces · Beijing Shijitan Hospital, Capital Medical University · Air Force General Hospital of the PLA · 309th Hospital of Chinese People's Liberation Army

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01391481 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials